Skip to main content
. 2018 Feb 23;13(2):e0192995. doi: 10.1371/journal.pone.0192995

Fig 4. Evaluation of RNAi-mediated impairment of Pgp 4 and 12 expression in the WT and IVR30 strain.

Fig 4

(A) Percentage of L3 paralysis percentage after 48 hours ivermectin exposure for groups Pgps 4 and 12 silenced [RNAi+], Pgps 4 and 12 non silenced [RNAi-] and negative control [CT], cultured only in M9 medium and not exposed to ivermectin treatment. (B) Assessement of L3 viability cell using propidium iodide marker after 48 hours ivermectin exposure in Pgps 4 and 12 silenced [RNAi+] and Pgps 4 and 12 non silenced [RNAi-] groups. P value refers to one-way ANOVA test with Turkey’s multiple comparisons test.